vs
Excelerate Energy, Inc.（EE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Excelerate Energy, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.5倍（$317.6M vs $207.3M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 15.7%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 26.0%）
Excelerate Energy是全球领先的灵活液化天然气（LNG）解决方案供应商，主营浮式储存再气化装置运营、LNG配送服务及一体化LNG基础设施项目，服务覆盖欧洲、亚洲、拉美、中东等地区，助力各地能源体系向低碳转型。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
EE vs RARE — 直观对比
营收规模更大
EE
是对方的1.5倍
$207.3M
营收增速更快
RARE
高出10.2%
15.7%
两年增速更快
RARE
近两年复合增速
26.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $317.6M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 22.2% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 15.7% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $0.24 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EERARE
| Q4 25 | $317.6M | $207.3M | ||
| Q3 25 | $391.0M | $159.9M | ||
| Q2 25 | $204.6M | $166.5M | ||
| Q1 25 | $315.1M | $139.3M | ||
| Q4 24 | $274.6M | $164.6M | ||
| Q3 24 | $193.4M | $139.5M | ||
| Q2 24 | $183.3M | $147.0M | ||
| Q1 24 | $200.1M | $108.8M |
净利润EERARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | — | $-180.4M | ||
| Q2 25 | — | $-115.0M | ||
| Q1 25 | — | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | — | $-133.5M | ||
| Q2 24 | — | $-131.6M | ||
| Q1 24 | — | $-170.7M |
营业利润率EERARE
| Q4 25 | 22.2% | -54.7% | ||
| Q3 25 | 22.3% | -106.9% | ||
| Q2 25 | 21.2% | -64.8% | ||
| Q1 25 | 20.9% | -102.6% | ||
| Q4 24 | 21.9% | -74.3% | ||
| Q3 24 | 30.9% | -94.6% | ||
| Q2 24 | 27.2% | -79.1% | ||
| Q1 24 | 22.6% | -151.9% |
净利率EERARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | — | -112.8% | ||
| Q2 25 | — | -69.0% | ||
| Q1 25 | — | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | — | -95.7% | ||
| Q2 24 | — | -89.5% | ||
| Q1 24 | — | -156.8% |
每股收益（稀释后）EERARE
| Q4 25 | $0.24 | $-1.28 | ||
| Q3 25 | $0.43 | $-1.81 | ||
| Q2 25 | $0.15 | $-1.17 | ||
| Q1 25 | $0.46 | $-1.57 | ||
| Q4 24 | $0.42 | $-1.34 | ||
| Q3 24 | $0.35 | $-1.40 | ||
| Q2 24 | $0.26 | $-1.52 | ||
| Q1 24 | $0.24 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $538.2M | $421.0M |
| 总债务越低越好 | $936.3M | — |
| 股东权益账面价值 | $2.2B | $-80.0M |
| 总资产 | $4.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.42× | — |
8季度趋势，按日历期对齐
现金及短期投资EERARE
| Q4 25 | $538.2M | $421.0M | ||
| Q3 25 | $462.6M | $202.5M | ||
| Q2 25 | $426.0M | $176.3M | ||
| Q1 25 | $619.5M | $127.1M | ||
| Q4 24 | $537.5M | $174.0M | ||
| Q3 24 | $608.4M | $150.6M | ||
| Q2 24 | $609.1M | $480.7M | ||
| Q1 24 | $578.9M | $112.3M |
总债务EERARE
| Q4 25 | $936.3M | — | ||
| Q3 25 | $942.0M | — | ||
| Q2 25 | $946.2M | — | ||
| Q1 25 | $322.6M | — | ||
| Q4 24 | $333.6M | — | ||
| Q3 24 | $345.7M | — | ||
| Q2 24 | $356.4M | — | ||
| Q1 24 | $366.9M | — |
股东权益EERARE
| Q4 25 | $2.2B | $-80.0M | ||
| Q3 25 | $2.2B | $9.2M | ||
| Q2 25 | $2.1B | $151.3M | ||
| Q1 25 | $1.9B | $144.2M | ||
| Q4 24 | $1.9B | $255.0M | ||
| Q3 24 | $1.9B | $346.8M | ||
| Q2 24 | $1.8B | $432.4M | ||
| Q1 24 | $1.8B | $140.3M |
总资产EERARE
| Q4 25 | $4.1B | $1.5B | ||
| Q3 25 | $4.1B | $1.2B | ||
| Q2 25 | $4.0B | $1.3B | ||
| Q1 25 | $2.9B | $1.3B | ||
| Q4 24 | $2.9B | $1.5B | ||
| Q3 24 | $2.9B | $1.5B | ||
| Q2 24 | $2.9B | $1.6B | ||
| Q1 24 | $2.9B | $1.3B |
负债/权益比EERARE
| Q4 25 | 0.42× | — | ||
| Q3 25 | 0.43× | — | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $104.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流EERARE
| Q4 25 | $104.4M | $-99.8M | ||
| Q3 25 | $114.9M | $-91.4M | ||
| Q2 25 | $87.1M | $-108.3M | ||
| Q1 25 | $154.8M | $-166.5M | ||
| Q4 24 | $49.6M | $-79.3M | ||
| Q3 24 | $39.8M | $-67.0M | ||
| Q2 24 | $90.4M | $-77.0M | ||
| Q1 24 | $64.7M | $-190.7M |
自由现金流EERARE
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
自由现金流率EERARE
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
资本支出强度EERARE
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EE
| Other | $179.4M | 57% |
| Revenue From Leases | $138.1M | 43% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
